Genetic Technologies Limited (GENE) EPS growth this year is -157.90%: Get Prepared for Trading Lift Off

Genetic Technologies Limited (NASDAQ: GENE) started the day on April 09, 2021, with a price increase of 6.53% at $4.57. During the day, the stock rose to $5.74 and sunk to $4.2301 before settling in for the price of $4.29 at the close. Taking a more long-term approach, GENE posted a 52-week range of $1.55-$10.30.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Meanwhile, its Annual Earning per share during the time was 29.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -157.90%. This publicly-traded company’s shares outstanding now amounts to $15.03 million, simultaneously with a float of $14.90 million. The organization now has a market capitalization sitting at $68.69 million. At the time of writing, stock’s 50-day Moving Average stood at $4.56, while the 200-day Moving Average is $3.80.

It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 64 workers. For the Profitability, stocks gross margin was -4485.32, operating margin was -75173.12 and Pretax Margin of -69433.60.

Genetic Technologies Limited (GENE) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. Genetic Technologies Limited’s current insider ownership accounts for 86.50%, in contrast to 1.90% institutional ownership.

Genetic Technologies Limited (GENE) Earnings and Revenue Records

This company achieved a net margin of -61830.19 while generating a return on equity of -82.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

Genetic Technologies Limited’s EPS decrease for this current 12-month fiscal period is -157.90%.

Genetic Technologies Limited (NASDAQ: GENE) Trading Performance Indicators

Let’s observe the current performance indicators for Genetic Technologies Limited (GENE). It’s Quick Ratio in the last reported quarter now stands at 14.50. The Stock has managed to achieve an average true range (ATR) of 0.42. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2671.19.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



In the same vein, GENE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.68.

Technical Analysis of Genetic Technologies Limited (GENE)

If we take a close look at the recent performances of Genetic Technologies Limited (NASDAQ: GENE), its last 5-days Average volume was 5.14 million that shows progress from its year to date volume of 2.07 million. During the previous 9 days, stock’s Stochastic %D was recorded 56.99% While, its Average True Range was 0.44.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Raw Stochastic average of Genetic Technologies Limited (GENE) in the period of the previous 100 days is set at 31.63%, which indicates a major fall in contrast to 38.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 65.63% that was lower than 106.99% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.